Coronary Angiography clinical trials

Explore recruiting coronary angiography clinical trials.

Recruiting coronary angiography studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coronary Angiography trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease needing coronarography.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial)

Finland, Iceland, Sweden, Denmark, Norway

Therapeutic use (Phase IV) EU CTIS Study details

Single antiplatelet treatment with Ticagrelor or Aspirin after Transcatheter Aortic Valve Implantation: multicenter randomized clinical trial

Spain, Italy, Portugal

Therapeutic use (Phase IV) EU CTIS Study details

PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of patients with total coronary occlusions with multimodality image.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3 prospective, blinded, randomized, placebo controlled, international multicenter study to assess the safety and efficacy of a single subcutaneous injection of zalunfiban in subjects with ST-elevation myocardial infarction in the pre-hospital setting

Netherlands, Romania, Czechia, France, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Coronary Angiography trials by city

Coronary Angiography in Toronto Coronary Angiography in Vancouver Coronary Angiography in Montreal Coronary Angiography in Calgary Coronary Angiography in Edmonton Coronary Angiography in Ottawa Coronary Angiography in Winnipeg Coronary Angiography in Quebec City Coronary Angiography in Hamilton Coronary Angiography in Kitchener Coronary Angiography in London Coronary Angiography in Halifax Coronary Angiography in New York Coronary Angiography in Los Angeles Coronary Angiography in Chicago Coronary Angiography in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease